CN101559203B - Chinese medicament preparation for treating angina pectoris - Google Patents
Chinese medicament preparation for treating angina pectoris Download PDFInfo
- Publication number
- CN101559203B CN101559203B CN2009100670464A CN200910067046A CN101559203B CN 101559203 B CN101559203 B CN 101559203B CN 2009100670464 A CN2009100670464 A CN 2009100670464A CN 200910067046 A CN200910067046 A CN 200910067046A CN 101559203 B CN101559203 B CN 101559203B
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicament
- prepared
- rhizoma
- angina pectoris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention provides a Chinese medicament preparation for treating angina pectoris, which is prepared from radix cyathulae, dragon blood, fresh nutgrass galingale rhizome, radix curcumae, white peony roots, cassia twig, pangolin scales, earthworms, rhizoma atractylodis macrocephalae, radix pseudostellariae, rhizoma alismatis, fingered citron, white tuckahoe, radix scrophulariae, shizandra and liquorice. The raw materials are prepared by a traditional Chinese medicament processing technique into the Chinese medicament preparation for treating coronary heart disease. The preparation is prepared from pure Chinese herbal medicines, has high therapeutic effect on coronary heart disease, treats both primary and secondary symptoms, is significant in therapeutic effect, has no adverse reactions,is few in toxic-side effect, enables clinical symptoms to disappear rapidly, and has no rebound phenomenon after cure.
Description
Technical field
The present invention discloses a kind of Chinese medicine preparation of treating angina pectoris, belongs to traditional Chinese medical science pharmaceutical technology field.
Technical background
Cards such as angina pectoris is called for short coronary heart disease, is the healthy common cardiovascular disease of a kind of serious harm human body, belongs to motherland's medical science " thoracic obstruction " " pained " disease categories such as " cardiopalmus ", and its clinical manifestation is angina pectoris, uncomfortable in chest, cardiopalmus, breathe hard.The method of treatment coronary heart disease mainly contains operative treatment and Drug therapy at present.Operative treatment comprises stenting and Coronary Artery Bypass.Postoperative patient has a delicate constitution, and is difficult to recover normal.Drug therapy comprises Western medicine and treatment by Chinese herbs, and it is main that Western medicine improves blood circulation with blood vessel dilating, and nitroglycerin commonly used etc. have certain curative effect for emergent medicine rescues, and are the link clinical symptoms, but cure the symptoms, not the disease.And Chinese medicine improves blood circulation with blood circulation promoting and blood stasis dispelling is main.Because turbid, the stagnation of QI of expectorant, blood stasis are the main pathogenic factor of coronary heart disease, it is true to belong to mark, visceral dysfunction, and negative and positive of qi and blood is become estranged, and it is empty to belong to this genuss, influences each other between the BIAO and BEN, and reciprocal causation is so that conventional tcm methods is fundamentally cured coronary heart disease is very difficult.
Summary of the invention
The present invention provides a kind of Chinese medicine preparation of treating angina pectoris, purpose be fundamentally to cure coronary heart disease.
Solution of the present invention is based on Chinese medicine the pathogenesis of coronary heart disease and Therapeutic Principle is the basis; Study in conjunction with modern medical theory; By controlling, kidney is bases of the five internal organs negative and positive, coordinates the physiological function between each internal organs from kidney; Yang blood and qi is tended to balance gradually, and expectorant is turbid, the stagnation of QI, blood stasis are washed away along with the normal operation of QI and blood gradually.Selected have a kidney and spleen invigorating, freeing vessels and nourishing heart, and reinforce functional activities of the heart, promoting blood circulation and stopping pain, the pure Chinese herbal medicine that thin network is regulated the flow of vital energy by the theory of Chinese medical science prescription, adopts the traditional Chinese medicines processing procedure through strict screening, processes Chinese medicine preparation.
Following consumption is weight portion, and basic recipe is following:
Medicine of the present invention is processed by following component: (consumption is a weight portion)
Radix Cyathulae 30 ~ 40, Sanguis Draxonis 15 ~ 20, living Rhizoma Cyperi 10 ~ 20, Radix Curcumae 10 ~ 15, the Radix Paeoniae Alba 15 ~ 20, Ramulus Cinnamomi 3 ~ 5, Squama Manis 10 ~ 15, Pheretima 10 ~ 15, the Rhizoma Atractylodis Macrocephalae 10 ~ 15, Radix Pseudostellariae 15 ~ 20, Rhizoma Alismatis 6 ~ 10, Fructus Citri Sarcodactylis 6 ~ 10, Poria 15 ~ 20, Radix Scrophulariae 10 ~ 15, Fructus Schisandrae Chinensis 6 ~ 10, Radix Glycyrrhizae 5 ~ 10.
The processing procedure of medicine of the present invention is following:
Above-mentioned each component drug is taken by weighing in proportion, and clean dry is ground into powder, filter through 80～120 orders, and mixing and stirring, the ripening sterilization is processed loose powder or pill.
The present invention also can process said other dosage form on the pharmaceutics by the Chinese medicine processing technology of routine.
[usage and consumption] every day twice, each 5～10 grams, boiled water send down.One～three month is a course of treatment.
[function with cure mainly] the kidney invigorating is soothing the liver, invigorating the spleen for dissipating phlegm, and the meridian dredging blood stasis dispelling stagnates.Cure mainly stabbing pain over the chest, uncomfortable in chest easypro, palpitation and uneasiness, diseases such as dyspnea with shortness of breath.
In prescription of the present invention:
The present invention is with Radix Cyathulae: blood circulation promoting and blood stasis dispelling, invigorating the liver and kidney, diuresis, conducting blood to flow downwards are monarch drug; It is minister that the XUEJIE SAN stasis ends all pains, specially goes into blood system; Assistant is with living Rhizoma Cyperi: up chest and diaphragm; Fructus Citri Sarcodactylis: liver-smoothing, qi-regulating and in reduce phlegm; Radix Curcumae: promoting QI circulation for relieving depression, removing heat from blood clear away heart-fire, promoting blood circulation and stopping pain; The Radix Paeoniae Alba: the yin fluid astringing that nourishes blood, easing the affected liver to relieve pain, suppressing the hyperactive liver sun; Ramulus Cinnamomi: warming the meridian for promoting the flow of YANG QI; Squama Manis: the meridian dredging; Pheretima: heat clearing away, collateral dredging, diuresis; Radix Pseudostellariae: tonifying QI to produce body fluid; Fructus Schisandrae Chinensis: nourishing kidney is promoted the production of body fluid, mind tranquilizing and the heart calming; The Rhizoma Atractylodis Macrocephalae: air making-up and spleen enlivening; Rhizoma Alismatis: dampness removing purges heat; Poria: invigorating spleen to remove dampness; Radix Scrophulariae: the heat-clearing and toxic substances removing yin nourishing, the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, synergism is played the kidney invigorating soothing liver and strengthening spleen altogether, regulates the yang blood and qi balance.
Good effect of the present invention is: preparation is that pure Chinese herbal medicine is processed, and is higher for the curative effect of coronary heart disease, and treating both the principal and secondary aspects of a disease is evident in efficacy, has no adverse reaction, and toxic and side effects is little, and clinical symptom disappearance is rapid, cures the no rebound phenomena in back.Therapeutic Method of the present invention is superior to the doctor trained in Western medicine operation pacemaker and western medicine is installed.
For showing the therapeutic effect of medicine of the present invention, take medicine of the present invention through following coronary heart disease case and observe:
Case 1:
The Wang, the man, 63 years old, suffered from angina pectoris 5 years, increased the weight of two months.Examine and see: pale tongue has indentation, greasy fur, and deep-slow pulse is unable, and Mental fatigue uncomfortable in chest is breathed hard, coldness of the body with chills, soreness of the waist and knees, card belongs to the deficiency of heart-YANG and kidney-YANG type, first YANG deficiency of kidney, the heart-yang helplessness, deficiency of heart-YANG and kidney-YANG, the cold coagulation blood that stagnates, numbness hinders heart arteries and veins, and is then uncomfortable in chest pained.Took medicine of the present invention two months, pained alleviating continued and obeyed two months, pained disappearance uncomfortable in chest, and after treatment is two months again, gets well.
Case 2:
Appoint certain, woman, 40 years old; Dizziness, xerostomia, vexed, uncomfortable in chest, pained, movingly then breathe hard, abdominal distention, aversion to cold and cold limbs, purple lip, thick fur are greasy, deep-thready pulse and puckery, the electrocardiogram prompting; Coronary heart disease, card belongs to deficiency of both YIN and YANG, dizziness, xerostomia, vexed be kidney yin can not on hold; Heart-fire can not dive, disarmony between the heart and kidney.Uncomfortable in chest, pained, movingly then breathe hard, abdominal distention, purple lip, deep-thready pulse and puckery be hepatic and renal YIN deficiency, pathogenic fire derived from stagnation of liver-QI, catharsis is unfavorable, mechanism of qi loses in bar and reaches, and forms qi depression to blood stasis; Aversion to cold and cold limbs is resembling of deficiency of spleen-YANG and kidneyYANG, yang-energy can not replenishing vital QI with drugs of warm nature extremity end slightly.Soreness of the waist and knees is resembling of hepatic and renal YIN deficiency.The rule of treatment: took medicine of the present invention two months, sx continues and obeyed two months, and pained disappearance uncomfortable in chest continues treatment two months, gets well.
Case 3:
Zhang, the woman, 72 years old, suffered from coronary heart disease 2 years, pained increasing the weight of a week, examining and see: feels oppressed in the anterior pectorial region, pain, abdominal distention, is breathed hard at spiritlessness and weakness, and is indigestion and loss of appetite, lusterless complexion, the loose stool, pale tongue is dark, greasy fur, relaxed and soft pulse.Insufficiency of kidney-YANG, dysfunction of the spleen in warming, fortuneization is unstrong, and essence of water and grain fortuneization is not enough.Money is given birth to weary source and the mechanism of qi operation is unfavorable, the difficult Zhou Quanshen of QI and blood, blood stasis due to qi deficiency numbness resistance heart arteries and veins, the rule of treatment: took medicine of the present invention two months; Carry out the treatment of kidney and spleen invigorating freeing vessels and nourishing heart, pained alleviating uncomfortable in chest continued and obeyed two months, examines: the moderate pulse light red tongue; Food is received cumulative, and heart-yang is gradually multiple, nurses one's health again two months, and electrocardiogram is normal; Clinical symptom disappearance, after treatment two months is got well.
The specific embodiment
Embodiment 1
Take by weighing Radix Cyathulae 40g, Sanguis Draxonis 20g, living Rhizoma Cyperi 10g, Radix Curcumae 10g, Radix Paeoniae Alba 15g, Ramulus Cinnamomi 5g, Squama Manis 15g, Pheretima 10g, Rhizoma Atractylodis Macrocephalae 10g, Radix Pseudostellariae 20g, Rhizoma Alismatis 10g, Fructus Citri Sarcodactylis 6g, Poria 18g, Radix Scrophulariae 10g, Fructus Schisandrae Chinensis 6g, Radix Glycyrrhizae 8g; Above-mentioned each component drug is taken by weighing in proportion; Clean dry is ground into powder, processes pill by the medicine pill preparation technology of routine.
Embodiment 2
Take by weighing Radix Cyathulae 30g, Sanguis Draxonis 15g, living Rhizoma Cyperi 20g, Radix Curcumae 15g, Radix Paeoniae Alba 20g, Ramulus Cinnamomi 3g, Squama Manis 10g, Pheretima 15g, Rhizoma Atractylodis Macrocephalae 15g, Radix Pseudostellariae 15g, Rhizoma Alismatis 8g, Fructus Citri Sarcodactylis 10g, Poria 20g, Radix Scrophulariae 15g, Fructus Schisandrae Chinensis 10g, Radix Glycyrrhizae 10; Above-mentioned each component drug is taken by weighing in proportion; Clean dry is ground into powder; Filter through 120 orders, mixing and stirring, the ripening sterilization is processed loose powder.
Embodiment 3
Take by weighing Radix Cyathulae 35g, Sanguis Draxonis 18g, living Rhizoma Cyperi 15g, Radix Curcumae 15g, Radix Paeoniae Alba 20g, Ramulus Cinnamomi 4g, Squama Manis 12g, Pheretima 15g, Rhizoma Atractylodis Macrocephalae 15g, Radix Pseudostellariae 20g, Rhizoma Alismatis 6g, Fructus Citri Sarcodactylis 10g, Poria 18g, Radix Scrophulariae 15g, Fructus Schisandrae Chinensis 10g, Radix Glycyrrhizae 10; Above-mentioned each component drug is taken by weighing in proportion, and clean dry is ground into powder, filter through 80～120 orders, and mixing and stirring, the ripening sterilization is processed loose powder.
Claims (2)
1. Chinese medicine preparation of treating angina pectoris is characterized in that by following raw materials by weight portion than processing:
Radix Cyathulae 30～40; Sanguis Draxonis 15～20; Living Rhizoma Cyperi 10～20; Radix Curcumae 10～15; The Radix Paeoniae Alba 15～20; Ramulus Cinnamomi 3～5; Squama Manis 10～15; Pheretima 10～15; The Rhizoma Atractylodis Macrocephalae 10～15; Radix Pseudostellariae 15～20; Rhizoma Alismatis 6～10; Fructus Citri Sarcodactylis 6～10; BAIFU
15～20; Radix Scrophulariae 10～15; Fructus Schisandrae Chinensis 6～10; Radix Glycyrrhizae 5～10.
2. the described Chinese medicine preparation of claim 1 is characterized in that by following raw materials by weight portion than processing:
Radix Cyathulae 40, Sanguis Draxonis 20, living Rhizoma Cyperi 10, Radix Curcumae 10, the Radix Paeoniae Alba 15, Ramulus Cinnamomi 5, Squama Manis 15, Pheretima 10, the Rhizoma Atractylodis Macrocephalae 10, Radix Pseudostellariae 20, Rhizoma Alismatis 10, Fructus Citri Sarcodactylis 6, BAIFU
18, Radix Scrophulariae 10, Fructus Schisandrae Chinensis 6, Radix Glycyrrhizae 8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100670464A CN101559203B (en) | 2009-06-03 | 2009-06-03 | Chinese medicament preparation for treating angina pectoris |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100670464A CN101559203B (en) | 2009-06-03 | 2009-06-03 | Chinese medicament preparation for treating angina pectoris |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101559203A CN101559203A (en) | 2009-10-21 |
| CN101559203B true CN101559203B (en) | 2012-01-04 |
Family
ID=41218295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100670464A Expired - Fee Related CN101559203B (en) | 2009-06-03 | 2009-06-03 | Chinese medicament preparation for treating angina pectoris |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101559203B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102755599B (en) * | 2012-08-02 | 2013-10-16 | 胡宇才 | Chinese medicine for treating yin deficiency, exogenous pathogens and thoracic obstruction in chest |
| CN103316286A (en) * | 2013-05-23 | 2013-09-25 | 太仓市胜舟生物技术有限公司 | Application of medicine in treatment stent post-operation angiogenesis promoting medicines |
| CN103316287A (en) * | 2013-05-23 | 2013-09-25 | 太仓市胜舟生物技术有限公司 | Application of traditional Chinese medicinal composition in preparation of treatment stent post-operation angiogenesis promoting medicines |
| CN104001104A (en) * | 2014-06-24 | 2014-08-27 | 河南中医学院 | Traditional Chinese medicine for treating qi deficiency and blood stasis caused after coronary artery bypass grafting |
| CN104013744B (en) * | 2014-06-26 | 2015-02-18 | 贵阳医学院 | Traditional Chinese medicine prescription for treating unstable angina pectoris of aged coronary heart disease |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1305844A (en) * | 2001-01-14 | 2001-08-01 | 刘红 | Medicine for treating congestive heart failure |
-
2009
- 2009-06-03 CN CN2009100670464A patent/CN101559203B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1305844A (en) * | 2001-01-14 | 2001-08-01 | 刘红 | Medicine for treating congestive heart failure |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101559203A (en) | 2009-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007191B (en) | Chinese medicinal composition for treating jaundice | |
| CN101274087A (en) | Chinese medicine decoction for invigorating gallbladder and removing gall-stone | |
| CN103705682B (en) | A kind of medicine for the treatment of lumbago due to pathogenic wind-dampness | |
| CN101559203B (en) | Chinese medicament preparation for treating angina pectoris | |
| CN103446575B (en) | Medicine for treating gout | |
| CN103007214B (en) | Chinese medicinal composition for treating palpitation | |
| CN102512645B (en) | Traditional Chinese medicine composition for treating lumbago due to cold dampness | |
| CN106177268B (en) | It is a kind of to treat Chinese medicine composition of impotence and preparation method thereof | |
| CN102512647B (en) | Chinese herbal composition for treating abdominal pain due to deficiency-cold | |
| CN101700390B (en) | Oral traditional Chinese medicine composition for treating fatty liver | |
| CN103041301A (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
| CN102512560A (en) | Traditional Chinese medicinal composition for treating arthromyodynia | |
| CN102430030B (en) | Chinese medicinal composition for treating bone impediment | |
| CN102600251B (en) | Rheumatism-rehabilitating traditional Chinese formulation | |
| CN101721518A (en) | Traditional Chinese medicine for treating senile constipation | |
| CN104857463A (en) | Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104491316B (en) | A kind of Chinese medicine preparation for the treatment of deficiency of QI in middle-JIAO type hyperplasia of prostate | |
| CN103230573A (en) | Traditional Chinese medicine preparation for treating endometriosis | |
| CN103007193B (en) | Chinese medicinal composition for treating gallbladder distention | |
| CN102652822A (en) | Traditional Chinese medicine oral liquid used for curing coronary heart disease | |
| CN101284116A (en) | Chinese medicine capsules for curing digestive system tumor | |
| CN104758888A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN105727140A (en) | Traditional Chinese medicine composition used for treating chronic renal failure | |
| CN105250864A (en) | Traditional Chinese medicine for treating visceral dysfunction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120104 Termination date: 20150603 |
|
| EXPY | Termination of patent right or utility model |